http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101229438-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55 |
| filingDate | 2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101229438-B1 |
| titleOfInvention | Omega-3 series lysophosphatidylcholine hydroxide derivatives having anti-inflammatory activity, or a pharmaceutically acceptable salt thereof, preparation method thereof, and anti-inflammatory composition containing the same as an active ingredient |
| abstract | The present invention relates to an omega-3 series lysophosphatidylcholine hydroxide derivative having anti-inflammatory activity or a pharmaceutically acceptable salt thereof, a preparation method thereof, and an anti-inflammatory composition containing the same as an active ingredient. lysophosphatidylcholine hydroxide derivatives in vivo (in In vivo ) inhibits zymosan A-induced peritonitis and is an anti-inflammatory factor mediators (LTC 4 , LTB 4 , PGE 2 ) or cytokines (IFN-γ, TNF-α, IL-2 and IL- 6) shows an excellent anti-inflammatory activity by inhibiting the production of, can be usefully used as an active ingredient in the pharmaceutical composition, health food or cosmetic composition for preventing and treating inflammatory diseases. |
| priorityDate | 2010-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 633.